Welcome to ACoP11

The ACoP11 Meeting Platform Link


Dear Colleagues,

On behalf of the Planning Committee, I cordially invite you to attend the Eleventh American Conference on Pharmacometrics (ACoP11), to be hosted virtually from 9 -13 November, 2020. ACoP is the annual scientific meeting of the International Society of Pharmacometrics (ISoP). 

The theme of ACoP11 is “Scaling New Heights.” This theme is aligned with ISoP's 5 year strategic plan that encompasses Scientific Expertise and Innovation, Influence, Education, Tools and Resources and Internationalization to actively champion the expanding role of pharmacometrics in protecting and improving human health. 

As always, ACoP11 will bring numerous exciting scientific sessions and poster presentations, plenary talks, SIG events, dedicated activities for our Student/Trainee community and ample networking opportunities for everyone. ACoP11 will also host a PreConference Event themed – “The Rising Role of Modeling in Oncology - From Translation to Confirmation”. The Planning Committee will be sharing further details for all participants including the session chairs, speakers, poster presenters, sponsors and exhibitors. You don’t want to miss it!

We recognize ACoP11 may be the first "virtual" conference for some...its a first for ACoP too!!! There may be questions related to the virtual meeting format and what to expect. Rest assured we will be answering any questions you may have. An AMA [ask me anything] session is planned soon (details to follow). We have designed this year’s ACoP11 virtual program to deliver exciting and valuable content and to encourage connection among attendees. We have shared some highlights about  the "virtual" platform.  (The ACoP11 Meeting Platform Link)

I look forward to connecting with you at ACoP11.


Navin Goyal, PhD
ACoP11 Chair

ACoP11 Registration - Now Open


Registration for ACoP11 is now open. Register now. See website for more details.

Group registration discounts! Please see details below before you register individually.